Express Scripts, Inc. vs. The Federal Trade Commission
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, Specialty, FTC, Express Scripts, Jake Auchincloss, PBM, GPO, Rebates, The Carlton Report, Spread Pricing
Valentines from the drug channel?
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, Rebates, WAC, MDRP, Triesence, Harrow, Krystexxa, Keveyis, Daranide, Buproprion, Olanzapine, Mesalamine, Albendazole, clobazam
Money from Sick People Part III: Why is U.S. drug pricing policy designed to exploit patients?
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, 340B, Medicaid, McKesson, pharmacy
How money from sick people works, Part II: The 340B story
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, CVS, 340B, Medicaid, McKesson, pharmacy
The unseasonably warm January drug price changes
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, Rebates, WAC, MDRP, American Rescue Plan Act, Advair, Asmanex, Symbicort, Apidra, Lantus, Levemir, Novolog, Victoza, Nucynta, Oxycontin, Butrans, Edarbi, Edarbyclor, Eliquis, Femring, Ferripox, Horizant, Verkazia, Wellbutrin, venlafaxine, lamotrigine, varenicline, atomoxetine
Contextualizing Drug Prices (Again)
Welcoming a New Year with new drug prices
Ben LinkMDRP, Rebates, Medicaid, WAC, List prices, Inflation, CPI, Inflation Reduction Act, Imbruvica, Farxiga, Jardiance, Biktarvy, Triumeq, Vyvanse, Price increases, Humira, Enbrel, Cosentyx, Norditropin, Otezla, Gilenya, Entresto, Uptravi, Promacta, Sabril
How low can you go? Newly launched dashboard explores 340B’s deeply discounted drug prices
As CMS drug pricing data remains missing, 46brooklyn finds solace in deflating generic drug costs
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, Rebates, Utilization, Spread, Acthar, Nuwiq, Wilate, Perseris, Lopid, Paliperidone, Duloxetine, Buprenorphine-Naloxone, Hydroxyzine, Gabapentin